Notice of Intent to Sole Source - Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB)

SOL #: 75N93024R00022Special Notice

Overview

Buyer

Health And Human Services
National Institutes Of Health
NATIONAL INSTITUTES OF HEALTH NIAID
BETHESDA, MD, 20892, United States

Place of Performance

Rockville, MD

NAICS

Research and Development in Biotechnology (except Nanobiotechnology) (541714)

PSC

Health R&D Services; Health Care Services; Applied Research (AN12)

Set Aside

No set aside specified

Timeline

1
Posted
Apr 3, 2026
2
Last Updated
May 7, 2026
3
Action Date
May 8, 2026, 7:00 PM

Qualification Details

Fit reasons
  • NAICS alignment with historical contract wins in similar service areas.
  • Scope strongly matches core technical capabilities and delivery model.
Risks
  • Past performance thresholds may require one additional teaming partner.
  • Potential clarification needed on staffing minimums before bid/no-bid.
Next steps

Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.

Quick Summary

The National Institute of Allergy and Infectious Diseases (NIAID), part of the NIH, is soliciting proposals for the continuation of the Chemistry Center for Combating Antibiotic-Resistant Bacteria (CC4CARB). This effort focuses on the design, synthesis, in vitro testing, and distribution of chemical libraries targeting Gram-negative bacterial pathogens and other antibiotic-resistant bacteria. While initially intended as a sole-source acquisition, this Firm-Fixed-Price contract is open to all responsible offerors. Proposals are due May 08, 2026, at 03:00 PM EST.

Scope of Work

The contract requires services across four key areas:

  • Library Design: Development of Individual Library Production Plans (ILPPs).
  • Compound Synthesis: Production of approximately 80 compounds per library, with flexibility for unanticipated chemistry.
  • Compound Testing: In vitro testing of new compounds.
  • Compound Management: Distribution of chemical libraries.
  • Project Management: Oversight of all efforts, including regular reporting (Monthly, Annual, Final Reports, ILPP-R, SSR, CTR).
  • Adherence to NIH policies on reproducibility, public access, dual-use research, and compliance with regulations for biological agents and highly pathogenic agents. Section 508 accessibility standards must also be met.

Contract & Timeline

  • Type: Firm-Fixed-Price Research and Development Contract
  • Duration: Base period from February 1, 2027, to January 31, 2028, with option periods extending through January 31, 2035.
  • Set-Aside: Not set-aside for small business.
  • NAICS: 541714 (Health R&D Services; Applied Research) with a 1000-employee size standard.
  • Proposal Due: May 08, 2026, 03:00 PM EST
  • Published: April 27, 2026 (Original RFP available April 08, 2026)
  • Place of Performance: Rockville, MD, United States

Evaluation

Proposals will be evaluated based on:

  • Technical Plan/Approach: 50%
  • Technical Personnel: 20%
  • Project Management: 20%
  • Facilities, Equipment, Resources: 10% Other factors include Price, Past Performance, and Subcontracting Program Evaluation Criteria. Compliance with Section 508 accessibility standards is also required.

Additional Notes

Proposals must be submitted electronically via the NIAID electronic Contract Proposal Submission (eCPS) website (https://ecps.nih.gov/). Offerors must acknowledge receipt of Amendment No. 0001, which provides answers to vendor inquiries and incorporates additional FAR clauses. The original solicitation was published with a "Notice of Intent to Sole Source" and a Justification and Approval (J&A) citing the unique capabilities of the incumbent, RTI International, and high transition costs. However, the RFP is open to all responsible offerors.

Contacts:

People

Points of Contact

Ignacio Reyes, Contracting OfficerPRIMARY
Jonathan BryanSECONDARY

Files

Files

Download
Download
Download

Versions

Version 4
Special Notice
Posted: May 7, 2026
View
Version 3Viewing
Special Notice
Posted: Apr 27, 2026
Version 2
Special Notice
Posted: Apr 9, 2026
View
Version 1
Solicitation
Posted: Apr 3, 2026
View